284 related articles for article (PubMed ID: 26471375)
1. Abnormal regulation of fibronectin production by fibroblasts in psoriasis.
Gubán B; Vas K; Balog Z; Manczinger M; Bebes A; Groma G; Széll M; Kemény L; Bata-Csörgő Z
Br J Dermatol; 2016 Mar; 174(3):533-41. PubMed ID: 26471375
[TBL] [Abstract][Full Text] [Related]
2. STAT1 expression and activation is increased in lesional psoriatic skin.
Hald A; Andrés RM; Salskov-Iversen ML; Kjellerup RB; Iversen L; Johansen C
Br J Dermatol; 2013 Feb; 168(2):302-10. PubMed ID: 23013371
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin.
Ting KM; Rothaupt D; McCormick TS; Hammerberg C; Chen G; Gilliam AC; Stevens S; Culp L; Cooper KD
J Invest Dermatol; 2000 Apr; 114(4):706-11. PubMed ID: 10733677
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis and extra domain A fibronectin loops.
McFadden JP; Baker BS; Powles AV; Fry L
Br J Dermatol; 2010 Jul; 163(1):5-11. PubMed ID: 20192957
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of keratinocyte growth factor and its receptor in psoriasis.
Finch PW; Murphy F; Cardinale I; Krueger JG
Am J Pathol; 1997 Dec; 151(6):1619-28. PubMed ID: 9403712
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of TGP on KGF‑induced hyperproliferation of HaCaT cells via suppression of the p38 MAPK/NF‑κB p65 pathway.
Pang W; Qi X; Cao C; Zhang S
Mol Med Rep; 2018 Aug; 18(2):2207-2215. PubMed ID: 29916542
[TBL] [Abstract][Full Text] [Related]
7. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
Zoppi N; Ritelli M; Colombi M
Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
[TBL] [Abstract][Full Text] [Related]
8. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
Suzuki H; Uchida K; Nitta K; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin and alpha5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin potentiation of T cell lymphokine-driven keratinocyte hyperproliferation in psoriasis.
Bata-Csorgo Z; Cooper KD; Ting KM; Voorhees JJ; Hammerberg C
J Clin Invest; 1998 Apr; 101(7):1509-18. PubMed ID: 9525994
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis.
Kovacs D; Falchi M; Cardinali G; Raffa S; Carducci M; Cota C; Amantea A; Torrisi MR; Picardo M
Exp Dermatol; 2005 Feb; 14(2):130-7. PubMed ID: 15679583
[TBL] [Abstract][Full Text] [Related]
11. Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin.
Széll M; Bata-Csörgo Z; Koreck A; Pivarcsi A; Polyánka H; Szeg C; Gaál M; Dobozy A; Kemény L
J Invest Dermatol; 2004 Sep; 123(3):537-46. PubMed ID: 15304094
[TBL] [Abstract][Full Text] [Related]
12. EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling.
Kohan M; Muro AF; White ES; Berkman N
FASEB J; 2010 Nov; 24(11):4503-12. PubMed ID: 20643910
[TBL] [Abstract][Full Text] [Related]
13. Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin.
Szlavicz E; Szabo K; Groma G; Bata-Csorgo Z; Pagani F; Kemeny L; Szell M
Mol Cell Biochem; 2017 Dec; 436(1-2):189-199. PubMed ID: 28589370
[TBL] [Abstract][Full Text] [Related]
14. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.
Kjellerup RB; Johansen C; Kragballe K; Iversen L
Br J Dermatol; 2013 Feb; 168(2):339-45. PubMed ID: 22924482
[TBL] [Abstract][Full Text] [Related]
15. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin.
Johansen C; Kragballe K; Westergaard M; Henningsen J; Kristiansen K; Iversen L
Br J Dermatol; 2005 Jan; 152(1):37-42. PubMed ID: 15656798
[TBL] [Abstract][Full Text] [Related]
16. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
17. Paracrine role of keratinocyte growth factor in rabbit corneal epithelial cell growth.
Sotozono C; Kinoshita S; Kita M; Imanishi J
Exp Eye Res; 1994 Oct; 59(4):385-91. PubMed ID: 7859813
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
[TBL] [Abstract][Full Text] [Related]
19. Expression of keratinocyte growth factor and its receptor in clear cell acanthoma.
Kovacs D; Cota C; Cardinali G; Aspite N; Bolasco G; Amantea A; Torrisi MR; Picardo M
Exp Dermatol; 2006 Oct; 15(10):762-8. PubMed ID: 16984257
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
